Tizanidine-1 (Tizanidine 1)
Tizanidine Tablet
Product Images NDC 76420-339
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 76420-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tizanidine-2 (Tizanidine 2)
This text provides information on the dosage and administration of Tizanidine capsules. It suggests taking 4 mg of Tizanidine either with or without food, and also indicates the time frame for dosing, showing the hours post-administration.*
Tizanidine-3 (Tizanidine 3)
Tizanidine-4 (Tizanidine 4)
This text provides information about an improvement in the Ashworth score measured at the end of titration (Study Week 3) and maintenance (Study Week 7) using a mean dose of 26.8 mg. The term "Endpoint" refers to the last observation carried forward in the study analysis.*
Label (Label 2mg)
This document appears to be a list of different Tizanidine Tablets, USP 2 mg products with various quantities and distribution details. The tablets are distributed by Sun Pharmasosusl Industries under the Enovachem brand. Each product comes with specific NDC numbers, lot numbers, and instructions to keep out of reach of children and store at a specific temperature range. The tablets are available in quantities ranging from 30 to 1000.*
Label (Label 4mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
